<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36732801</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>Suppl 6</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Leveraging process mining for modeling progression trajectories in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>346</StartPage><MedlinePgn>346</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">346</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-023-02113-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease whose spreading and progression mechanisms are still unclear. The ability to predict ALS prognosis would improve the patients' quality of life and support clinicians in planning treatments. In this paper, we investigate ALS evolution trajectories using Process Mining (PM) techniques enriched to both easily mine processes and automatically reveal how the pathways differentiate according to patients' characteristics.</AbstractText><AbstractText Label="METHODS">We consider data collected in two distinct data sources, namely the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) dataset and a real-world clinical register (ALS-BS) including data of patients followed up in two tertiary clinical centers of Brescia (Italy). With a focus on the functional abilities progressively impaired as the disease progresses, we use two Process Discovery methods, namely the Directly-Follows Graph and the CareFlow Miner, to mine the population disease trajectories on the PRO-ACT dataset. We characterize the impairment trajectories in terms of patterns, timing, and probabilities, and investigate the effect of some patients' characteristics at onset on the followed paths. Finally, we perform a comparative study of the impairment trajectories mined in PRO-ACT versus ALS-BS.</AbstractText><AbstractText Label="RESULTS">We delineate the progression pathways on PRO-ACT, identifying the predominant disabilities at different stages of the disease: for instance, 85% of patients enter the trials without disabilities, and 48% of them experience the impairment of Walking/Self-care abilities first. We then test how a spinal onset increases the risk of experiencing the loss of Walking/Self-care ability as first impairment (52% vs. 27% of patients develop it as the first impairment in the spinal vs. the bulbar cohorts, respectively), as well as how an older age at onset corresponds to a more rapid progression to death. When compared, the PRO-ACT and the ALS-BS patient populations present some similarities in terms of natural progression of the disease, as well as some differences in terms of observed trajectories plausibly due to the trial scheduling and recruitment criteria.</AbstractText><AbstractText Label="CONCLUSIONS">We exploited PM to provide an overview of the evolution scenarios of an ALS trial population and to preliminary compare it to the progression observed in a clinical cohort. Future work will focus on further improving the understanding of the disease progression mechanisms, by including additional real-world subjects as well as by extending the set of events considered in the impairment trajectories.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Via Gradenigo 6/b, 35131, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatta</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25121, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallati</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Computing and Engineering, University of Huddersfield, Huddersfield, HD1 3DH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotti Piccinelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25121, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeMO-Brescia Clinical Center for Neuromuscular Diseases, Via Paolo Richiedei 16, 25064, Gussago, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filosto</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25121, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeMO-Brescia Clinical Center for Neuromuscular Diseases, Via Paolo Richiedei 16, 25064, Gussago, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padovani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25121, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Neurology, ASST Spedali Civili, Piazzale Spedali Civili 1, 25123, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25121, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Camillo</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8415-4688</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Via Gradenigo 6/b, 35131, Padua, Italy. barbara.dicamillo@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Comparative Biomedicine and Food Science, University of Padova, Agripolis, Viale dell'Universit&#xe0;, 16, 35020, Legnaro, Italy. barbara.dicamillo@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/T041196/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RF-2016-02362405</GrantID><Agency> Italian Ministry of Health</Agency><Country/></Grant><Grant><GrantID>'Research Grant (type B) - junior' initiative</GrantID><Agency>Universit&#xe0; degli Studi di Padova</Agency><Country/></Grant><Grant><GrantID>2017SNW5MB</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Patient stratification</Keyword><Keyword MajorTopicYN="N">Process discovery</Keyword><Keyword MajorTopicYN="N">Process mining</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Progression trajectories</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>0</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36732801</ArticleId><ArticleId IdType="pmc">PMC9896660</ArticleId><ArticleId IdType="doi">10.1186/s12911-023-02113-7</ArticleId><ArticleId IdType="pii">10.1186/s12911-023-02113-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beghi E, Chi&#xf2; A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux P-M, Pupillo E. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler. 2011;12(1):1&#x2013;10. doi: 10.3109/17482968.2010.502940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.502940</ArticleId><ArticleId IdType="pmc">PMC3513399</ArticleId><ArticleId IdType="pubmed">20698807</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal NA, Berry JD, Windebank A, Staff NP, Maragakis NJ, van den Berg LH, Genge A, Miller R, Baloh RH, Kern R, Gothelf Y, Lebovits C, Cudkowicz M. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve. 2020;62(2):156&#x2013;166. doi: 10.1002/mus.26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, Li G, Fang L, Mackey L, Hardiman O. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol. 2015;33(1):51. doi: 10.1038/nbt.3051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3051</ArticleId><ArticleId IdType="pubmed">25362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kueffner R, Zach N, Bronfeld M, Norel R, Atassi N, Balagurusamy V, Di Camillo B, Chio A, Cudkowicz M, Dillenberger D. Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach. Sci Rep. 2019;9(1):690. doi: 10.1038/s41598-018-36873-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36873-4</ArticleId><ArticleId IdType="pmc">PMC6345935</ArticleId><ArticleId IdType="pubmed">30679616</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Le Chat G, Secchi-Buhour M-S, Delbot F, Pradat-Peyre J-F, Bede P, Pradat P-F. Manifold learning for amyotrophic lateral sclerosis functional loss assessment. J Neurol. 2021;268(3):825&#x2013;850. doi: 10.1007/s00415-020-10181-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10181-2</ArticleId><ArticleId IdType="pubmed">32886252</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, Debray TP, Visser AE, van Eijk RP, Rooney JP, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17(5):423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Couratier P, Arcuti S, Copetti M, Fontana A, Nicol M, Raymondeau M, Logroscino G, Preux PM. Stratification of ALS patients&#x2019; survival: a population-based study. J Neurol. 2016;263(1):100&#x2013;111. doi: 10.1007/s00415-015-7940-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7940-z</ArticleId><ArticleId IdType="pubmed">26518423</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AA, Fournier C, Polak M, Wang L, Zach N, Keymer M, Glass JD, Ennist DL. Consortium PRO-A.A.C.T.: predicting disease progression in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2016;3(11):866&#x2013;875. doi: 10.1002/acn3.348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.348</ArticleId><ArticleId IdType="pmc">PMC5099532</ArticleId><ArticleId IdType="pubmed">27844032</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreiro AV, Amaral PM, Pinto S, Tom&#xe1;s P, de Carvalho M, Madeira SC. Prognostic models based on patient snapshots and time windows: predicting disease progression to assisted ventilation in amyotrophic lateral sclerosis. J Biomed Inform. 2015;58:133&#x2013;144. doi: 10.1016/j.jbi.2015.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.09.021</ArticleId><ArticleId IdType="pubmed">26455265</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller M, Gromicho M, de Carvalho M, Madeira SC. Explainable models of disease progression in ALS: Learning from longitudinal clinical data with recurrent neural networks and deep model explanation. Comput Methods Programs Biomed Update. 2021;1:100018. doi: 10.1016/j.cmpbup.2021.100018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpbup.2021.100018</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30</Citation></Reference><Reference><Citation>Tavazzi E, Daberdaku S, Zandon&#xe0; A, Vasta R, Nefussy B, Lunetta C, Mora G, Mandrioli J, Grisan E, Tarlarini C et al. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression. J Neurol. 2022;1&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217910</ArticleId><ArticleId IdType="pubmed">35266043</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreiro AV, Pinto S, de Carvalho M, Madeira SC, Antunes C. Classification of clinical data using sequential patterns: a case study in amyotrophic lateral sclerosis. In: 2nd workshop on data mining in healthcare and medicine, at SIAM International Conf on Data Mining; 2013.</Citation></Reference><Reference><Citation>Zaki MJ, Meira W, Jr, Meira W. Data mining and analysis: fundamental concepts and algorithms. Cambridge: Cambridge University Press; 2014.</Citation></Reference><Reference><Citation>Martins AS, Gromicho M, Pinto S, de Carvalho M, Madeira SC. Learning prognostic models using diseaseProgression patterns: predicting the need forNon-invasive ventilation in amyotrophic lateralSclerosis. IEEE/ACM Trans Comput Biol Bioinf. 2021;19(5):2572&#x2013;2583.</Citation><ArticleIdList><ArticleId IdType="pubmed">33961562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomeni R, Fava M. Pooled resource open-access ALS clinical trials consortium: amyotrophic lateral sclerosis disease progression model. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1&#x2013;2):119&#x2013;129. doi: 10.3109/21678421.2013.838970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.838970</ArticleId><ArticleId IdType="pubmed">24070404</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A, Group BAS complete listing of the BDNF Study Group, A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1-2):13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hansen-Flaschen J, Wileyto EP, Schwab RJ, Elman L, Kawut SM. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J. 2019;53(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684229</ArticleId><ArticleId IdType="pubmed">30728207</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Lapin BR, Kinzy TG, Pioro EP. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(7&#x2013;8):483&#x2013;494. doi: 10.1080/21678421.2018.1484925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1484925</ArticleId><ArticleId IdType="pubmed">30001159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi E, Daberdaku S, Vasta R, Calvo A, Chi&#xf2; A, Di Camillo B. Exploiting mutual information for the imputation of static and dynamic mixed-type clinical data with an adaptive k-nearest neighbours approach. BMC Med Inform Decis Mak. 2020;20(5):1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439551</ArticleId><ArticleId IdType="pubmed">32819346</ArticleId></ArticleIdList></Reference><Reference><Citation>van&#xa0;der Aalst W, Adriansyah A. Process mining manifesto. In: International conference on business process management, Springer; 2011. pp. 169&#x2013;194.</Citation></Reference><Reference><Citation>van der Aalst W, Weijters T, Maruster L. Workflow mining: discovering process models from event logs. IEEE Trans Knowl Data Eng. 2004;16(9):1128&#x2013;1142. doi: 10.1109/TKDE.2004.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TKDE.2004.47</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Aalst W, Adriansyah A, van Dongen B. Replaying history on process models for conformance checking and performance analysis. Wiley Interdiscip Rev Data Min Knowl Discov. 2012;2(2):182&#x2013;192. doi: 10.1002/widm.1045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/widm.1045</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Aalst W. Process mining: discovery, conformance and enhancement of business processes. 2011;136. 10.1007/978-3-642-19345-3.</Citation></Reference><Reference><Citation>Lenz R, Reichert M. IT support for healthcare processes-premises, challenges, perspectives. Data Knowl Eng. 2007;61(1):39&#x2013;58. doi: 10.1016/j.datak.2006.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.datak.2006.04.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas E, Munoz-Gama J, Sep&#xfa;lveda M, Capurro D. Process mining in healthcare: a literature review. J Biomed Inform. 2016;61:224&#x2013;236. doi: 10.1016/j.jbi.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.04.007</ArticleId><ArticleId IdType="pubmed">27109932</ArticleId></ArticleIdList></Reference><Reference><Citation>De Roock E, Martin N. Process mining in healthcare&#x2013;an updated perspective on the state of the art. J Biomed Inform. 2022;103995</Citation><ArticleIdList><ArticleId IdType="pubmed">35077900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusuma G, Hall M, Johnson O. Process mining in cardiology: a literature review. Int. J. Biosci. Biochem. Bioinform. 2018;8:226&#x2013;236.</Citation></Reference><Reference><Citation>Balakhontceva MA, Funkner AA, Semakova AA, Metsker OG, Zvartau NE, Yakovlev AN, Lutsenko AE, Kovalchuk SV. Holistic modeling of chronic diseases for recommendation elaboration and decision making. Procedia Comput Sci. 2018;138:228&#x2013;237. doi: 10.1016/j.procs.2018.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2018.10.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurniati AP, Johnson O, Hogg D, Hall G. Process mining in oncology: a literature review. In: 2016 6th international conference on information communication and management (ICICM), IEEE; 2016. pp. 291&#x2013;297.</Citation></Reference><Reference><Citation>Dagliati A, Tibollo V, Cogni G, Chiovato L, Bellazzi R, Sacchi L. Careflow mining techniques to explore type 2 diabetes evolution. J Diabetes Sci Technol. 2018;12(2):251&#x2013;259. doi: 10.1177/1932296818761751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296818761751</ArticleId><ArticleId IdType="pmc">PMC5851241</ArticleId><ArticleId IdType="pubmed">29493360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi E, Gerard CL, Michielin O, Wicky A, Gatta R, Cuendet MA. A process mining approach to statistical analysis: application to a real-world advanced melanoma dataset. In: International conference on process mining, Springer; 2020. pp. 291&#x2013;304.</Citation></Reference><Reference><Citation>Williams R, Rojas E, Peek N, Johnson OA. Process mining in primary care: a literature review. Stud Health Technol Inform. 2018;247:376&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677986</ArticleId></ArticleIdList></Reference><Reference><Citation>Litchfield I, Hoye C, Shukla D, Backman R, Turner A, Lee M, Weber P. Can process mining automatically describe care pathways of patients with long-term conditions in UK primary care? a study protocol. BMJ Open. 2018;8(12):019947. doi: 10.1136/bmjopen-2017-019947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019947</ArticleId><ArticleId IdType="pmc">PMC6286474</ArticleId><ArticleId IdType="pubmed">30518578</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Millana A, Lizondo A, Gatta R. Process mining dashboard in operating rooms: analysis of staff expectations with analytic hierarchy process. Int J Environ Res Public Health. 2019;16(2):199. doi: 10.3390/ijerph16020199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16020199</ArticleId><ArticleId IdType="pmc">PMC6352092</ArticleId><ArticleId IdType="pubmed">30642000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens S, Gailly F, Van&#xa0;Sassenbroeck D, Poels G. Integrated declarative process and decision discovery of the emergency care process. Inf Syst Front. 1&#x2013;23 (2020)</Citation></Reference><Reference><Citation>Yang W-S, Hwang S-Y. A process-mining framework for the detection of healthcare fraud and abuse. Expert Syst Appl. 2006;31(1):56&#x2013;68. doi: 10.1016/j.eswa.2005.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2005.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Jin T, Wang J. Extracting clinical-event-packages from billing data for clinical pathway mining. In: International conference on smart health, Springer; 2016. pp. 19&#x2013;31.</Citation></Reference><Reference><Citation>Gerhardt R, Valiati JF, dos Santos JVC. An investigation to identify factors that lead to delay in healthcare reimbursement process: a Brazilian case. Big Data Res. 2018;13:11&#x2013;20. doi: 10.1016/j.bdr.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bdr.2018.02.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Weijters A, van&#xa0;der Aalst WM, De&#xa0;Medeiros AA. Process mining with the heuristics miner-algorithm. Technische Universiteit Eindhoven, Tech. Rep. WP; 2006. 166, pp. 1&#x2013;34.</Citation></Reference><Reference><Citation>Leemans SJ, Fahland D, van&#xa0;der Aalst WM. Discovering block-structured process models from event logs-a constructive approach. In: International conference on applications and theory of petri nets and concurrency, Springer, 2013. pp. 311&#x2013;329.</Citation></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(1):38&#x2013;44. doi: 10.1136/jnnp-2013-306589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther CW, van&#xa0;der Aalst WM. Fuzzy mining&#x2013;adaptive process simplification based on multi-perspective metrics. In: International conference on business process management, Springer; 2007. pp. 328&#x2013;343.</Citation></Reference><Reference><Citation>Gatta R, Vallati M, Lenkowicz J, Rojas E, Damiani A, Sacchi L, De Bari B, Dagliati A, Fernandez-Llatas C, Montesi M, Marchetti A, Castellano M, Valentini V. Generating and comparing knowledge graphs of medical processes using pminer. 2017. 10.1145/3148011.3154464.</Citation></Reference><Reference><Citation>Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz M. The PRO-ACT database design, initial analyses, and predictive features. Neurology. 2014;83(19):1719&#x2013;1725. doi: 10.1212/WNL.0000000000000951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000951</ArticleId><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, Calvo A, Gabriele M. ALS clinical trials: Do enrolled patients accurately represent the ALS population? Neurology. 2011;77(15):1432&#x2013;1437. doi: 10.1212/WNL.0b013e318232ab9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318232ab9b</ArticleId><ArticleId IdType="pubmed">21956723</ArticleId></ArticleIdList></Reference><Reference><Citation>ALS CNTF treatment study (ACTS) phase I-II study group: the amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996; 53(2): 141&#x2013;147. 10.1001/archneur.1996.00550020045014</Citation><ArticleIdList><ArticleId IdType="pubmed">8639063</ArticleId></ArticleIdList></Reference><Reference><Citation>Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ. ALSFRS and appel ALS scores: discordance with disease progression. Muscle Nerve Off J Am Assoc Electrodiagn Med. 2008;37(5):668&#x2013;672. doi: 10.1002/mus.20977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20977</ArticleId><ArticleId IdType="pubmed">18288708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P, Massagli M, Wolf C, Heywood J. Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol. 2009;16(3):353&#x2013;359. doi: 10.1111/j.1468-1331.2008.02434.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02434.x</ArticleId><ArticleId IdType="pubmed">19364363</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MD, Swash M. Awaji diagnostic algorithm increases sensitivity of EL escorial criteria for ALS diagnosis. Amyotroph Lateral Scler. 2009;10(1):53&#x2013;57. doi: 10.1080/17482960802521126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B.G., Consortium, E., Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Gama J, Martin N, Fernandez-Llatas C, Johnson OA, Sep&#xfa;lveda M, Helm E, Galvez-Yanjari V, Rojas E, Martinez-Millana A, Aloini D et al. Process mining for healthcare: characteristics and challenges. J Biomed Inform. 2022;103994.</Citation><ArticleIdList><ArticleId IdType="pubmed">35104641</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52(1&#x2013;2):93&#x2013;103. doi: 10.1159/000493386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatta R, Vallati M, Lenkowicz J, Masciocchi C, Cellini F, Boldrini L, Fernandez&#xa0;Llatas C, Valentini V, Damiani A. On the feasibility of distributed process mining in healthcare. In: International conference on computational science, Springer; 2019. pp. 445&#x2013;452.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>